CRISPR/Cas9-mediated correction of human genetic disease

doi:10.1007/s11427-017-9032-4

Review

. 2017 May;60(5):447-457.

doi: 10.1007/s11427-017-9032-4. Epub 2017 May 3.

CRISPR/Cas9-mediated correction of human genetic disease

Ke Men¹, Xingmei Duan^{2

3}, Zhiyao He⁴, Yang Yang², Shaohua Yao², Yuquan Wei²

Affiliations

¹ State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. mendingbob@hotmail.com.
² State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
³ Individualized Medication Key Laboratory of Sichuan Province, Department of Pharmacy, Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People's Hospital, Sichuan Translational Medicine Hospital, Chengdu, 610072, China.
⁴ Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.

PMID: 28534256
DOI: 10.1007/s11427-017-9032-4

Review

CRISPR/Cas9-mediated correction of human genetic disease

Ke Men et al. Sci China Life Sci. 2017 May.

. 2017 May;60(5):447-457.

doi: 10.1007/s11427-017-9032-4. Epub 2017 May 3.

Authors

Ke Men¹, Xingmei Duan^{2

3}, Zhiyao He⁴, Yang Yang², Shaohua Yao², Yuquan Wei²

Affiliations

¹ State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. mendingbob@hotmail.com.
² State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
³ Individualized Medication Key Laboratory of Sichuan Province, Department of Pharmacy, Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People's Hospital, Sichuan Translational Medicine Hospital, Chengdu, 610072, China.
⁴ Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.

PMID: 28534256
DOI: 10.1007/s11427-017-9032-4

Abstract

The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) protein 9 system (CRISPR/Cas9) provides a powerful tool for _targeted genetic editing. Directed by programmable sequence-specific RNAs, this system introduces cleavage and double-stranded breaks at _target sites precisely. Compared to previously developed _targeted nucleases, the CRISPR/Cas9 system demonstrates several promising advantages, including simplicity, high specificity, and efficiency. Several broad genome-editing studies with the CRISPR/Cas9 system in different species in vivo and ex vivo have indicated its strong potential, raising hopes for therapeutic genome editing in clinical settings. Taking advantage of non-homologous end-joining (NHEJ) and homology directed repair (HDR)-mediated DNA repair, several studies have recently reported the use of CRISPR/Cas9 to successfully correct disease-causing alleles ranging from single base mutations to large insertions. In this review, we summarize and discuss recent preclinical studies involving the CRISPR/Cas9-mediated correction of human genetic diseases.

Keywords: CRISPR/Cas9; gene therapy; genetic disease; genome editing.

PubMed Disclaimer

Cited by

Cationic micelle-based siRNA delivery for efficient colon cancer gene therapy.
Lu Y, Zhong L, Jiang Z, Pan H, Zhang Y, Zhu G, Bai L, Tong R, Shi J, Duan X. Lu Y, et al. Nanoscale Res Lett. 2019 Jun 4;14(1):193. doi: 10.1186/s11671-019-2985-z. Nanoscale Res Lett. 2019. PMID: 31165329 Free PMC article.
Therapeutic Applications of the CRISPR-Cas System.
Kang K, Song Y, Kim I, Kim TJ. Kang K, et al. Bioengineering (Basel). 2022 Sep 15;9(9):477. doi: 10.3390/bioengineering9090477. Bioengineering (Basel). 2022. PMID: 36135023 Free PMC article. Review.
Low-density lipoprotein receptor-related protein 1 is a CROPs-associated receptor for Clostridioides infection toxin B.
Guo S, Chen Y, Liu J, Zhang X, Liu Z, Zhou Z, Wei W. Guo S, et al. Sci China Life Sci. 2022 Jan;65(1):107-118. doi: 10.1007/s11427-021-1943-9. Epub 2021 Jul 15. Sci China Life Sci. 2022. PMID: 34279819
Recent advances in mammalian reproductive biology.
Wen L, Liu Q, Xu J, Liu X, Shi C, Yang Z, Zhang Y, Xu H, Liu J, Yang H, Huang H, Qiao J, Tang F, Chen ZJ. Wen L, et al. Sci China Life Sci. 2020 Jan;63(1):18-58. doi: 10.1007/s11427-019-1572-7. Epub 2019 Nov 29. Sci China Life Sci. 2020. PMID: 31813094 Review.
The evolving CRISPR technology.
Yan M, Li J. Yan M, et al. Protein Cell. 2019 Nov;10(11):783-786. doi: 10.1007/s13238-019-0645-9. Protein Cell. 2019. PMID: 31243729 Free PMC article. Review. No abstract available.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

CRISPR/Cas9-mediated correction of human genetic disease

Affiliations

CRISPR/Cas9-mediated correction of human genetic disease

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical